Evidence map›Paper›PMID 26913524›Full record

ReviewWiener medizinische Wochenschrift (1946)2016

[Management of secondary hyperparathyroidism-current impact of parathyroidectomy].

Emanuel Zitt, Karl Lhotta

Abstract readComparative StudyReview
PubMed Publisher
In one paragraph

Review in Wiener medizinische Wochenschrift (1946), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Emanuel ZittAbteilung für Nephrologie und Dialyse, Akademisches Lehrkrankenhaus LKH Feldkirch, Carinagasse 47, 6800, Feldkirch, Österreich. emanuel.zitt@lkhf.at.
Karl LhottaAbteilung für Nephrologie und Dialyse, Akademisches Lehrkrankenhaus LKH Feldkirch, Carinagasse 47, 6800, Feldkirch, Österreich.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parathyroidectomy still presents an adequate and efficient therapeutic option for the management of refractory secondary hyperparathyroidism (sHPT). Dependent on the selected surgical technique it allows the highest rate of "laboratory cure" of sHPT. The question remains as to whether these improvements translate into clinical long-term benefits regarding the sHPT-associated vascular calcification and the increased risk for cardiovascular morbidity and mortality as well as overall mortality. Recent large observational studies point in this direction but definite evidence through prospective randomized controlled trials is still lacking.

Indexed as

ParathyroidectomyCase-Control StudiesFollow-Up StudiesHumansHyperparathyroidism, SecondaryKidney Failure, ChronicObservational Studies as TopicRenal DialysisSurvival RateDialysisParathyroidectomySecondary hyperparathyroidism

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.